Abiopharma

New Form 4 - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088163 Size: 5 KB

Axsome Therapeutics Champions Brain Health During Alzheimers & Brain Awareness Month

IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant

New Form 6-K - Haleon plc Filed: 2025-06-20 AccNo: 0001654954-25-007209 Size: 34 KB

Exelixis’ Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors

New Form IRANNOTICE - Medtronic plc Filed: 2025-06-20 AccNo: 0001613103-25-000092 Size: 6 KB

New Form 10-K - Medtronic plc Filed: 2025-06-20 AccNo: 0001613103-25-000091 Size: 24 MB

New Form 6-K - AURORA CANNABIS INC Filed: 2025-06-20 AccNo: 0001279569-25-000645 Size: 46 KB

New Form 4 - Silence Therapeutics plc Filed: 2025-06-20 AccNo: 0001104659-25-060862 Size: 7 KB

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA

New Form 8-K - Evolent Health, Inc. Filed: 2025-06-20 AccNo: 0001628908-25-000098 Size: 311 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Madrigal Receives Positive CHMP Opinion for Resmetirom(Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis

New Form 8-K - PetVivo Holdings, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015708 Size: 544 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

New Form 8-K - PROVECTUS BIOPHARMACEUTICALS, INC. Filed: 2025-06-20 AccNo: 0001641172-25-015695 Size: 208 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form SCHEDULE 13D - Tharimmune, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015693 Size: 12 KB